Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapy

Quansheng Zhou(Soochow University), Peng Xu

Research Square

January 8, 2024

10.21203/rs.3.rs-3677039/v1

Cited by 0

Related Papers

CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis

|Cell Death and Disease|2014|101

The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers

|Cell Death and Disease|2023|17

The H3K4 methyltransferase KMT2D is an essential cofactor for GATA1 at erythroid gene enhancers

|Research Square|2025|0